{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-reconciling-paper-and-electronic-records”
},
“headline”: “SOP for Reconciling Paper and Electronic Records”,
“description”: “This SOP establishes procedures for reconciling paper and electronic records in clinical trials, ensuring consistency, completeness, and compliance with FDA, EMA, CDSCO, WHO, GDPR, HIPAA, and ICH GCP requirements. It includes hybrid TMF/ISF management, duplicate verification, version control, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Reconciling Paper and Electronic Records

Purpose

The purpose of this SOP is to define standardized procedures for reconciling paper and electronic records in clinical trials, ensuring consistency, accuracy, and compliance. Hybrid records (paper + electronic) must be harmonized to maintain data integrity, subject safety, and regulatory inspection readiness.

Scope

This SOP applies to sponsors, investigators, CROs, QA, archivists, and data management personnel handling Trial Master File (TMF), Investigator Site File (ISF), source documents, and essential clinical trial data maintained in both paper and electronic formats. It covers reconciliation, duplicate management, version control, and archiving.

Responsibilities

• Sponsor: Defines reconciliation requirements and ensures oversight of CRO/vendor compliance.
• Investigators: Maintain ISF reconciliation between paper and electronic copies.
• Archivist: Ensures both paper and eArchives are synchronized.
• QA: Conducts audits to confirm consistency of hybrid records.
• Data Management: Manages electronic record updates and versioning.

Accountability

The Sponsor is accountable for ensuring reconciliation processes are defined and implemented. Investigators are accountable for site-level hybrid records, while QA is accountable for compliance verification.

Procedure

1. Identification of Hybrid Records
1.1 Identify documents existing in both paper and electronic formats.
1.2 Maintain Hybrid Record Register (Annexure-1).

2. Reconciliation of TMF and ISF
2.1 Compare paper and electronic TMF/ISF contents quarterly.
2.2 Ensure versions are aligned and discrepancies documented.
2.3 Record reconciliation in TMF/ISF Reconciliation Log (Annexure-2).

3. Duplicate Verification
3.1 Confirm duplicate records contain identical content and signatures.
3.2 Where discrepancies exist, mark as “Superseded” and retain original.

4. Version Control
4.1 Each document must have version numbers and effective dates.
4.2 Ensure electronic version reflects paper version updates and vice versa.

5. Archiving of Hybrid Records
5.1 Archive paper and electronic records under the same index structure.
5.2 Maintain Archive Reconciliation Log (Annexure-3).

6. Regulatory Compliance
6.1 Ensure reconciliation practices comply with FDA, EMA, CDSCO, WHO, GDPR, and HIPAA requirements.
6.2 Maintain inspection readiness at all times.

7. Deviation Management
7.1 Record all reconciliation failures in Deviation Log (Annexure-4).
7.2 Investigate and implement CAPA.

Abbreviations

• SOP: Standard Operating Procedure
• TMF: Trial Master File
• ISF: Investigator Site File
• QA: Quality Assurance
• CRO: Contract Research Organization
• CAPA: Corrective and Preventive Action
• GDPR: General Data Protection Regulation
• HIPAA: Health Insurance Portability and Accountability Act

Documents

1. Hybrid Record Register (Annexure-1)
2. TMF/ISF Reconciliation Log (Annexure-2)
3. Archive Reconciliation Log (Annexure-3)
4. Deviation Log (Annexure-4)

References

• ICH E6(R2/R3) – Essential Documents in Clinical Trials
• FDA – Guidance on Clinical Trial Records
• EMA – Paper and Electronic Record Requirements
• CDSCO – Record Keeping Regulations
• WHO – Data Integrity and Record Management

Version: 1.0

Approval Section

Annexures

Annexure-1: Hybrid Record Register

Annexure-2: TMF/ISF Reconciliation Log

Annexure-3: Archive Reconciliation Log

Annexure-4: Deviation Log

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-tmf-filing-during-the-trial-quality-checks-timeliness”
},
“headline”: “SOP for TMF Filing During the Trial (Quality Checks, Timeliness)”,
“description”: “This SOP defines the step-by-step procedures for filing documents into the Trial Master File (TMF) during an ongoing trial, ensuring contemporaneous updates, quality checks, version control, and inspection readiness in compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for TMF Filing During the Trial (Quality Checks, Timeliness)

Purpose

The purpose of this SOP is to establish a standardized process for contemporaneous filing of essential documents into the Trial Master File (TMF) during the conduct of a clinical trial. This ensures that all trial-related records are accurate, complete, current, and readily available for inspection by regulatory authorities.

Scope

This SOP applies to sponsor staff, CROs, monitors (CRAs), TMF administrators, and QA officers responsible for filing, maintaining, and reviewing trial-related essential documents in TMF/eTMF during the trial. It includes timelines, quality control, reconciliation, versioning, and compliance monitoring for global clinical studies.

Responsibilities

• Sponsor: Ensures TMF/eTMF is accurate, contemporaneous, and inspection-ready.
• CRO: May manage TMF on behalf of sponsor, but oversight remains with sponsor.
• Clinical Operations: Ensures timely submission of documents for filing.
• CRA: Collects and submits site-level documents for TMF filing.
• TMF Administrator: Files documents, manages placeholders, performs QC checks.
• QA: Audits TMF periodically for compliance and inspection readiness.

Accountability

The Head of Clinical Operations is accountable for overall TMF completeness. TMF administrators are accountable for timeliness and accuracy of filing, while QA is accountable for verifying quality standards.

Procedure

1. Document Collection and Submission
1.1 CRAs and study staff must submit finalized essential documents (e.g., approvals, consents, monitoring reports) within 5 working days of finalization.
1.2 Documents should be submitted in controlled formats (signed originals, certified copies, or validated e-documents).
1.3 TMF placeholders must be updated until documents are available.

2. Filing into TMF/eTMF
2.1 TMF administrators classify and index documents as per TMF structure and DIA Reference Model.
2.2 File documents under “During the Trial” section in TMF index.
2.3 Ensure documents are filed only once and in correct section; duplicates must be avoided.
2.4 Apply audit trails (electronic) or date/initial stamps (paper).

3. Timeliness Requirements
3.1 All essential documents must be filed within 5 working days of receipt/finalization.
3.2 Exceptions must be justified in TMF Filing Deviation Log (Annexure-1).
3.3 Monthly metrics for timeliness (% filed on time) must be tracked.

4. Quality Control Checks
4.1 Perform QC on 10% of documents filed weekly.
4.2 QC includes verifying signatures, dates, version control, completeness, and accuracy.
4.3 Record QC results in TMF QC Log (Annexure-2).
4.4 Discrepancies must be corrected within 10 working days.

5. Reconciliation and Tracking
5.1 Monthly reconciliation must be conducted between TMF, ISF, and monitoring reports.
5.2 Track missing documents in TMF Reconciliation Log (Annexure-3).
5.3 Notify responsible function (site/CRO/sponsor) for overdue documents.

6. Version Management
6.1 Superseded versions must be archived and controlled.
6.2 For eTMF, audit trails must capture changes; for paper TMF, stamp “Superseded.”
6.3 Document corrections must follow SOP for Document Corrections.

7. Ongoing Compliance and Inspection Readiness
7.1 TMF must be inspection-ready at all times.
7.2 Monthly TMF completeness and timeliness reports must be generated.
7.3 QA audits TMF quarterly and documents findings in QA Audit Log.

Abbreviations

• SOP: Standard Operating Procedure
• TMF/eTMF: Trial Master File / electronic Trial Master File
• CRA: Clinical Research Associate
• QC: Quality Control
• QA: Quality Assurance
• DIA: Drug Information Association
• ISF: Investigator Site File

Documents

1. TMF Filing Deviation Log (Annexure-1)
2. TMF QC Log (Annexure-2)
3. TMF Reconciliation Log (Annexure-3)

References

• ICH E6(R2/R3) – Essential Documents During Trial
• FDA – TMF Filing Guidance
• EMA – TMF Filing and Maintenance
• CDSCO – Essential Documents Filing
• WHO – TMF Quality and Timeliness

Version: 1.0

Approval Section

Annexures

Annexure-1: TMF Filing Deviation Log

Annexure-2: TMF QC Log

Annexure-3: TMF Reconciliation Log

Revision History

For more SOPs visit: Pharma SOP